Physician profile
Daniel Marks
NPI 1457794406
$93,654.57
in general payments reported to CMS, 2019-2025
26 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $8,939 · 2022: $14K · 2023: $8,011 · 2024: $18K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,125 · Consulting Fee: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $18,436.48 |
| Food and Beverage | $16,226.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,125.00 |
| Consulting Fee | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,611.36 | 2019-2025 | Farapulse, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $20,197.50 | 2019-2025 | Ensite Precision, Ensite, Merlin@Home |
| Medtronic Vascular, INC. | $16,300.16 | 2019-2020 | |
| Medtronic, INC. | $9,293.35 | 2021-2025 | Pulseselect, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $6,147.23 | 2021-2025 | Acticor 7 Vr-T Dx, Selectra, Pamira |
| Medical Device Business Services, INC. | $2,875.32 | 2022-2024 | Carto 3 |
| Biosense Webster, INC. | $2,833.89 | 2021-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Atricure, INC. | $1,704.59 | 2023 | |
| Siemens Medical Solutions USA, INC. | $1,650.00 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $708.99 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $209.18 | 2022-2025 | Assure Wcd |
| Abiomed | $197.92 | 2021 | |
| Cardiva Medical, INC. | $168.51 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Volta Medical INC | $163.03 | 2025 | Vx1 |
| Sanofi-Aventis U.S. LLC | $145.81 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $137.36 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $95.35 | 2024 | Optimizer |
| Stryker Corporation | $39.30 | 2025 | Triathlon |
| Pfizer INC. | $31.37 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $28.77 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.24 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $26.68 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.00 | 2024 | Arcalyst |
| Amgen INC. | $17.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.14 | 2021 | |
| Chiesi USA, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.